Former OpenAI science lead Kevin Weil has launched Warp Sciences, a new AI startup focused on automating lab work for drug discovery. The company, which trains robots to make and test promising compounds identified by researchers, has raised $215 million at an $865 million valuation, according to Weil, who announced the startup and funding on X.
The round was led by Lightspeed, with participation from IVP, Premji Invest, and Lux Capital.
Originally reported by TechCrunch. Read the full story at the original source.
CommentLoaderSave StorySave this storyCommentLoaderSave StorySave this storyI’m not even going to try to pretend I don’t...
'Mass Effect: Universe' looks like it would have focused on a new protagonist and series favorite Liara T'So...
Ole Bielfeldt of Germany captured a microscopic view of an inkjet printer depositing ink onto paper.
Concerns have swirled over the access that consumers are increasingly entrusting to AI agents. Now, security services ar...